Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

Sleep ended up being the biggest predictor of having a cardiovascular disease event and dying from any cause. The underlying ...

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Doctors at Northwell Health in New York are using mammograms to help identify women at risk for heart disease.

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...